TrialThe Journal of clinical psychiatry2016

Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial.

Carolyn I Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.